๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma

โœ Scribed by Qian He; Shu-Qun Zhang; Yong-Lie Chu; Xiao-Li Jia; Xiang-Ling Wang

Publisher
Springer
Year
2008
Tongue
English
Weight
209 KB
Volume
36
Category
Article
ISSN
0301-4851

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

c-erbB-2 over-expression in amplified an
c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples
โœ Fulvia Farabegoli; Claudio Ceccarelli; Donatella Santini; Nicola Baldini; Mario ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 124 KB ๐Ÿ‘ 1 views

We investigated c-erbB-2 oncogene amplification and overexpression in 79 invasive breast carcinoma samples using fluorescence in situ hybridization (FISH) and immunohistochemistry, with the aim of studying relationships between neoplasms over-expressing c-erbB-2 with or without amplification and bio

Prognostic value of p53, bcl-2, and c-er
Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas
โœ de Krijger, Ronald R.; van der Harst, Erwin; van der Ham, Frieda; Stijnen, Theo; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 260 KB ๐Ÿ‘ 2 views

Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was p

ErbB2 overexpression correlates with inc
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma
โœ Wentao Yang; Kristine Klos; Ying Yang; Terry L. Smith; Daren Shi; Dihua Yu ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 858 KB

## Abstract ## BACKGROUND The angiogenic factor vascular endothelial growth factor (VEGF)โ€A plays an important role in breast cancer progression. However, the involvement of VEGFโ€C and VEGFโ€D, two newer members of the VEGF family, in breast carcinoma and their relationship with clinicopathologic p